Kura Oncology (KURA) Invested Capital: 2024-2025
Historic Invested Capital for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to $246.9 million.
- Kura Oncology's Invested Capital fell 41.98% to $246.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $246.9 million, marking a year-over-year decrease of 41.98%. This contributed to the annual value of $416.2 million for FY2024, which is N/A change from last year.
- According to the latest figures from Q3 2025, Kura Oncology's Invested Capital is $246.9 million, which was down 20.00% from $308.6 million recorded in Q2 2025.
- In the past 5 years, Kura Oncology's Invested Capital ranged from a high of $505.1 million in Q1 2024 and a low of $246.9 million during Q3 2025.
- For the 2-year period, Kura Oncology's Invested Capital averaged around $390.8 million, with its median value being $416.2 million (2024).
- Data for Kura Oncology's Invested Capital shows a maximum YoY slumped of 41.98% (in 2025) over the last 5 years.
- Quarterly analysis of 2 years shows Kura Oncology's Invested Capital stood at $416.2 million in 2024, then plummeted by 41.98% to $246.9 million in 2025.
- Its last three reported values are $246.9 million in Q3 2025, $308.6 million for Q2 2025, and $366.3 million during Q1 2025.